Skip to content

GoodRx Holdings, Inc. GDRX Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin92.8%-1.1pp93.9%+2.8pp91.1%-0.4pp91.5%-2.2pp
Operating margin11%+2.7pp8.3%+11.9pp-3.6%-3.8pp0.2%-1.6pp
Net margin3.8%+1.8pp2.1%+3.3pp-1.2%+3.1pp-4.3%-0.9pp
Returns
Return on equity4.5%+2.3pp2.2%+3.3pp-1.1%+2.9pp-4%-0.7pp
Return on invested capital5.5%+1.3pp4.2%+7.7pp-3.4%-3.7pp0.3%-2.3pp
Efficiency
Asset turnover0.6×0.0×0.5×+0.1×0.5×0.0×0.5×0.0×
Liquidity
Current ratio2.6×-2.7×5.3×-1.8×7.1×-4.9×12.1×-1.4×
Leverage
Debt-to-equity0.9×+0.1×0.7×-0.2×0.9×+0.1×0.9×0.0×
Net debt / EBITDA1.6×+0.9×0.7×+0.2×0.5×+1.2×-0.7×+4.3×
Per Share
Book value per share$1.73-6.6%$1.85-0.5%$1.86-5.9%$1.97-2.7%
Valuation
Market capitalization$934.74M-43.1%$1.77B-34.4%$2.7B+40.8%$1.92B-85.8%
Price / earnings45.5×-12.3×108.1×
Price / sales1.2×-0.9×2.2×-1.4×3.6×+1.1×2.5×-15.7×
Price / book1.5×-1.0×2.4×-1.1×3.5×+1.2×2.4×-13.9×
EV / EBITDA7.6×-4.5×13.8×-20.2×34×+0.4×33.6×-244×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are GoodRx Holdings, Inc.'s profit margins?
GoodRx Holdings, Inc. (GDRX) runs a 91.8% gross margin and a 9.9% operating margin, with a 2.6% net margin.
Where do GoodRx Holdings, Inc.'s ratios come from?
Every ratio is computed from GoodRx Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.